Olanzapine for the Treatment of Chronic Nausea and/or Vomiting in Advanced Cancer Patients

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
The purpose of this study is to evaluate the use of olanzapine for the treatment of cancer patients with chronic nausea and/or vomiting unrelated to chemotherapy or radiation in a randomized placebo-controlled pilot trial.
Epistemonikos ID: 1657965385feb1432307bdf03622014edea7b3b8
First added on: May 20, 2024